Moody National Bank Trust Division acquired a new stake in Boston Scientific Co. (NYSE:BSX – Free Report) during the 4th ...
Dr. Greg Vigna Spinal cord stimulators are linked to over 80,000 injuries, with lead migration and hematomas causing severe harm <b ...
Claro Advisors LLC purchased a new stake in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the fourth quarter, ...
A range of spinal cord stimulators have been approved by the FDA, but none specifically for SCI patients. Abbott, Medtronic and Boston Scientific all have products indicated for chronic pain.
Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...